Fulgent Genetics FLGT is set to give its latest quarterly earnings report on Friday, 2024-11-08. Here's what investors need to know before the announcement.
Analysts estimate that Fulgent Genetics will report an earnings per share (EPS) of $-0.15.
The market awaits Fulgent Genetics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
In the previous earnings release, the company beat EPS by $0.45, leading to a 0.0% drop in the share price the following trading session.
Here's a look at Fulgent Genetics's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.30 | -0.32 | -0.29 | -0.33 |
| EPS Actual | 0.15 | -0.01 | 0.28 | -0.39 |
| Price Change % | 6.0% | 1.0% | -4.0% | 13.0% |
Tracking Fulgent Genetics's Stock Performance
Shares of Fulgent Genetics were trading at $22.68 as of November 06. Over the last 52-week period, shares are down 14.28%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for Fulgent Genetics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
